Evidence for neuroprotective effect of sulbutiamine against oxygen-glucose deprivation in rat hippocampal CA1 pyramidal neurons

Jeehyun Kwag, Aman Shah Abdul Majid, Kui Dong Kang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Hippocampus is one of the earliest brain regions that gets affected by ischemia, however, no pharmacological therapy exists yet that can fully counteract the ischemic damage. Here we study the effect of sulbutiamine, a synthetic thiamine analogue that can cross the blood-brain barrier easily, on hippocampal neurons under an in vitro model of ischemia, oxygen-glucose deprivation (OGD). We find that exposure to OGD in the presence of sulbutiamine significantly increases neuronal viability and enhances electrophysiological properties such as excitatory synaptic transmissions and intrinsic neuronal membrane input resistance in a concentration-dependent manner. Overall, here we report, for the first time, the neuroprotective evidence of sulbutiamine on hippocampal CA1 pyramidal neurons under OGD, which may have beneficial implications as a possible therapeutic agent/substance against ischemic insult.

Original languageEnglish
Pages (from-to)1759-1764
Number of pages6
JournalBiological and Pharmaceutical Bulletin
Volume34
Issue number11
DOIs
Publication statusPublished - 2011 Nov 1

Fingerprint

sulbutiamine
Pyramidal Cells
Neuroprotective Agents
Oxygen
Glucose
Ischemia
Thiamine
Blood-Brain Barrier
Synaptic Transmission
Hippocampus
Pharmacology
Neurons
Membranes
Brain
Therapeutics

Keywords

  • Hippocampus
  • Neuroprotec
  • Oxygen-glucose deprivation
  • Sulbutiamine

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology

Cite this

Evidence for neuroprotective effect of sulbutiamine against oxygen-glucose deprivation in rat hippocampal CA1 pyramidal neurons. / Kwag, Jeehyun; Majid, Aman Shah Abdul; Kang, Kui Dong.

In: Biological and Pharmaceutical Bulletin, Vol. 34, No. 11, 01.11.2011, p. 1759-1764.

Research output: Contribution to journalArticle

@article{aaeccca507d14e5d8ac7aff0560c943c,
title = "Evidence for neuroprotective effect of sulbutiamine against oxygen-glucose deprivation in rat hippocampal CA1 pyramidal neurons",
abstract = "Hippocampus is one of the earliest brain regions that gets affected by ischemia, however, no pharmacological therapy exists yet that can fully counteract the ischemic damage. Here we study the effect of sulbutiamine, a synthetic thiamine analogue that can cross the blood-brain barrier easily, on hippocampal neurons under an in vitro model of ischemia, oxygen-glucose deprivation (OGD). We find that exposure to OGD in the presence of sulbutiamine significantly increases neuronal viability and enhances electrophysiological properties such as excitatory synaptic transmissions and intrinsic neuronal membrane input resistance in a concentration-dependent manner. Overall, here we report, for the first time, the neuroprotective evidence of sulbutiamine on hippocampal CA1 pyramidal neurons under OGD, which may have beneficial implications as a possible therapeutic agent/substance against ischemic insult.",
keywords = "Hippocampus, Neuroprotec, Oxygen-glucose deprivation, Sulbutiamine",
author = "Jeehyun Kwag and Majid, {Aman Shah Abdul} and Kang, {Kui Dong}",
year = "2011",
month = "11",
day = "1",
doi = "10.1248/bpb.34.1759",
language = "English",
volume = "34",
pages = "1759--1764",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "11",

}

TY - JOUR

T1 - Evidence for neuroprotective effect of sulbutiamine against oxygen-glucose deprivation in rat hippocampal CA1 pyramidal neurons

AU - Kwag, Jeehyun

AU - Majid, Aman Shah Abdul

AU - Kang, Kui Dong

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Hippocampus is one of the earliest brain regions that gets affected by ischemia, however, no pharmacological therapy exists yet that can fully counteract the ischemic damage. Here we study the effect of sulbutiamine, a synthetic thiamine analogue that can cross the blood-brain barrier easily, on hippocampal neurons under an in vitro model of ischemia, oxygen-glucose deprivation (OGD). We find that exposure to OGD in the presence of sulbutiamine significantly increases neuronal viability and enhances electrophysiological properties such as excitatory synaptic transmissions and intrinsic neuronal membrane input resistance in a concentration-dependent manner. Overall, here we report, for the first time, the neuroprotective evidence of sulbutiamine on hippocampal CA1 pyramidal neurons under OGD, which may have beneficial implications as a possible therapeutic agent/substance against ischemic insult.

AB - Hippocampus is one of the earliest brain regions that gets affected by ischemia, however, no pharmacological therapy exists yet that can fully counteract the ischemic damage. Here we study the effect of sulbutiamine, a synthetic thiamine analogue that can cross the blood-brain barrier easily, on hippocampal neurons under an in vitro model of ischemia, oxygen-glucose deprivation (OGD). We find that exposure to OGD in the presence of sulbutiamine significantly increases neuronal viability and enhances electrophysiological properties such as excitatory synaptic transmissions and intrinsic neuronal membrane input resistance in a concentration-dependent manner. Overall, here we report, for the first time, the neuroprotective evidence of sulbutiamine on hippocampal CA1 pyramidal neurons under OGD, which may have beneficial implications as a possible therapeutic agent/substance against ischemic insult.

KW - Hippocampus

KW - Neuroprotec

KW - Oxygen-glucose deprivation

KW - Sulbutiamine

UR - http://www.scopus.com/inward/record.url?scp=81455128689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81455128689&partnerID=8YFLogxK

U2 - 10.1248/bpb.34.1759

DO - 10.1248/bpb.34.1759

M3 - Article

VL - 34

SP - 1759

EP - 1764

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 11

ER -